Eris Lifesciences Limited (BOM:540596)
India · Delayed Price · Currency is INR 1,342.05
+4.30 (0.32%)
At close: Mar 27, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 185.77 billion as of March 27, 2026. Its market cap has increased by 7.46% in one year.
Market Cap
185.77B
Enterprise Value
213.04B
Revenue
30.65B
Ranking
n/a
PE Ratio
43.10
Stock Price
1,342.05
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 185.77B, an increase of 124.62%. That is a compound annual growth rate of 9.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 185.77B | -9.42% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 393.29B |
| J. B. Chemicals & Pharmaceuticals | 334.36B |
| AstraZeneca Pharma India | 210.39B |
| Granules India | 155.80B |
| Jubilant Pharmova | 136.99B |
| Rubicon Research | 127.45B |
| Caplin Point Laboratories | 121.29B |
| CORONA Remedies | 96.79B |